Non-clinical safety assessment of BPN14770 to support pediatric population with fragile X syndrome
Ended Awarded Last action
- Contract number
- 75N95018F00005
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $789,821
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR172002 · Posted Apr 7, 2020
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Award Notice · Posted May 2, 2016
- Contract value 100% obligated
- $789,821.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$112,475 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $902,296 |
About this award
This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to the IIT Research Institute, a non-profit organization and the research arm of the Illinois Institute of Technology. The $789,821.36 contract provides non-clinical safety assessment of the drug candidate BPN14770 to support the pediatric population with Fragile X Syndrome. This order falls under the broader "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" indefinite delivery/indefinite quantity (IDIQ) contract vehicle. No set-aside designation was used. As a prime contractor, IIT Research Institute has experience conducting preclinical drug testing services for the National Institutes of Health across various therapeutic areas.
Quick answers
Who was awarded contract 75N95018F00005?
75N95018F00005 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 7, 2018.
How much is contract 75N95018F00005 worth?
The government has obligated $789,821 on 75N95018F00005.
Which agency awarded contract 75N95018F00005?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95018F00005, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95018F00005 an order under another contract?
Yes. 75N95018F00005 is a delivery order under HHSN271201700016I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract 75N95018F00005 competed?
The extent of competition for 75N95018F00005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award